The Pilot Study Evaluate the Safety and Efficacy of Sirolimus in Patients With PIK3CA Mutation and/or PIK3CA Amplification Refractory Solid Tumors
Clinical trial NCT02449564 · COMPLETED
Trial details
- NCT number
- NCT02449564
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-24
- Primary completion
- 2017-09-27
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.